Early adoption of Collagen/ORC therapies improves clinical outcomes in both venous leg ulcers and diabetic foot ulcers.

Methods: Diabetic foot ulcers and venous leg ulcers were treated with Collagen/ORC or Collagen/ORC/Silver for up to 12 weeks and wound area was measured on a weekly basis. In this study we used 2 outcome measures; response to treatment, and complete healing. Response to treatment was based on percentage reduction after 4 weeks of treatment and healing at week 12. Diabetic foot ulcers achieving at least 50% reduction in wound area over the first 4 weeks, or venous leg ulcers showing at least 30% reduction in wound area over the first 4 weeks were classed as responders, wounds not achieving this percentage reduction were classed as non responders. Healing was defined as 100% epithelialisation.